By: Ham Lord, Chairman of Launchpad Venture Group and Co-Founder of Seraf-investor.com and Christopher Mirabile, ACA Chair Emeritus, Managing Director at Launchpad Venture Group and Co-Founder of Seraf-investor.com

Note: This article is the eleventh in an ongoing series for angels new to investing. To learn more about building an angel portfolio, download this free eBook today - Angel 101: A Primer for Angel Investors or purchase our books at Amazon.com.

In the first two parts of this series on angel exits, we examined four different types of successful exits and four different types of failed exits. With our final article in the series we will address a few miscellaneous topics that are important for angel investors to understand as they build a diversified portfolio. And, for another take on angel exits, please read our article on an introduction to angels and exits.

By: Kevin Learned and Denise Dunlap, Boise Angel Alliance

Terms like “warrants, waterfalls and preferences” can be confusing and intimidating when attempting to understand a capitalization table (aka cap table); it is no wonder we are often asked for a simple way to understand them! This article will give a brief overview of why cap tables are important and introduce a simple model to use early in the due diligence process.

By: Ham Lord, Chairman of Launchpad Venture Group and Co-Founder of Seraf-investor.com and Christopher Mirabile, ACA Chair Emeritus, Managing Director at Launchpad Venture Group and Co-Founder of Seraf-investor.com

Note: This article is the ninth in an ongoing series for angels new to investing. To learn more about building an angel portfolio, download this free eBook today Angel 101: A Primer for Angel Investors or purchase our books at Amazon.com.

After a year or two down the path of building a diversified portfolio of angel investments, many individual angels are faced with some uncertainty about their path forward. The questions on many experienced angels’ minds are “Will I make a good enough return on my angel investments to justify the risk? Should I continue to invest?”

By Lucy Howell, ACA Director of Partnerships 

The seventh annual Innovation Showcase took place last week at the 2019 ACA Summit in Chicago.  This special series of events provides selected companies the opportunity to present their pitch to the entire ACA Summit audience over the course of the Summit.  The Innovation Showcase is by invitation only and presenting companies are nominated by organizations - ACA member angel groups, venture funds, accelerators, and universities government agencies or trade commissions - that underwrite the Innovation Showcase.  The “showcase” represents an incredible opportunity for these underwriters to showcase their best portfolio companies to the angel investors and startup ecosystem leaders at the Summit.

By Sarah Dickey, ACA Membership Director

The Angel Capital Association had the very distinct honor of awarding Marianne Hudson the Hans Severiens Award at the 2019 ACA Summit in Chicago.  This annual national award recognizes one individual’s work in advancing the field of angel investing.  The criteria for this prominent award include depth of the individual’s impact on advancement of angel investing, leadership in bringing awareness of the field and contribution to the knowledge base of angel investing.  Marianne clearly demonstrates these qualities through her work in founding the association and growing it as ACA’s Executive Director.  ACA has become an important institution for angel investors and the startup ecosystem, providing education, data, smart practices and public policy advocacy for angel investors in every American state and five Canadian provinces.

By Sarah Dickey, ACA Membership Director

Congratulations to Joylux, a Seattle based women’s health technology company, which was awarded the Luis Villalobos Award today at the 2019 ACA Summit in Chicago.  The Luis Villalobos Award recognizes outstanding ingenuity, creativity and innovation among startups backed by ACA members.

By: Ronald F.E. Weissman, Ph.D., Band of Angels and Member, ACA Board of Directors

(Editor’s Note:  Ron Weissman will present a session on artificial intelligence at the 2019 ACA Summit in Chicago, April 24-26.  Get a sneak peek of the “intelligence on artificial intelligence” ahead of the event.)

Artificial Intelligence is on the verge of transforming almost everything, from your medical diagnosis to the way you select your next home, to detecting an audience’s emotional reaction to an ad or TV pilot, to predicting, in silico, if a drug is likely to kill you.  Given the success and spread of AI, how should we approach investing in this technically complex and rapidly evolving field?

By:  Ethel Rubin, Entrepreneur-in-Residence, National Institutes of Health

Editors Note:  ACA has entered into an annual partnership program with NIH, with an aim toward collaboration and getting to know early-stage companies funded through NIH funding programs such as Small Business Innovation Research grants.

Some wonderful new things are happening at the National Institutes of Health (NIH) to help the companies we have backed make further progress. Our angel investors should be aware of specialized funding and support programs that were reauthorized last year so that your portfolio companies can take a look and see if they qualify.  The three most relevant are the extension of the NIH Entrepreneurs in Residence initiative; SBIR Direct to Phase II grants; and the Commercialization Readiness Pilot Program.

By: Ham Lord, Chairman of Launchpad Venture Group and Co-Founder of Seraf-investor.com and Christopher Mirabile, ACA Chair Emeritus, Managing Director at Launchpad Venture Group and Co-Founder of Seraf-investor.com

Note: This article is the third in an ongoing series for angels new to investing. To learn more about building an angel portfolio, download this free eBook today - Angel 101: A Primer for Angel Investors or purchase our books at Amazon.com.

New angels, new entrepreneurs and people outside of the startup ecosystem may have a general sense of how early stage investments happen, but, if put on the spot and asked to describe the exact process, most would be hard-pressed to come up with much detail at all. Like cooking, changing a tire, playing a sport well, and so many other things in life, the angel process is simple in theory, but a bit more complicated in practice. The angel process is not rocket science, but there are a lot of steps, there is some complexity, and there can definitely be some science to doing some of the steps well.

By: Marianne Hudson, ACA Executive Director

You have probably heard by now that ACA is moving forward with our initiative to be the premier source of angel investment data.  Our first step was releasing the inaugural Angel Funders Report with data from 26 angel groups and 432 investment rounds in 2017, and we will be releasing new reports soon that will eventually improve our member groups’ investments.  So, why is data important to early-stage investing and why should your group join the ACA’s data initiative?  There are so many reasons!  Data insights provide the knowledge to make smarter decisions giving you and your angel group a step up when making portfolio assessments and increasing your chance for success.  Read on for some of our top reasons why joining the ACA data analytics initiative and the Angel Funders Report can make everyone better angel investors: